PRIMO NUTRACEUTICALS INC. (CSE:PRMO) (OTC:BUGVF) (FSE:8BV) (DEU:8BV) (MUN:8BV) (STU:8BV) (“Primo” or the “Company”) is pleased to announce that it has satisfied the provisions of the information guidelines of National Policy 12-203, by filing its annual financial statements and MD&A for the year ended July 31, 2019, and therefore its cease trade order has been lifted and as of March 5, 2020 the Company is once again trading on the CSE under the symbol: PRMO. The Company was not subject to any insolvency proceedings.
The Company also announces the appointment of Mr. Mark Bechtel as Corporate Secretary.
Mr. Bechtel is a securities lawyer with extensive experience in Canadian capital markets and exchanges. Presently Mr. Bechtel operates a law firm located in downtown Vancouver specializing in venture and emerging markets. As Corporate Secretary of Primo Mr. Bechtel will ensure that best practices for regulatory compliance are established and maintained.
The Company has also entered into a consulting agreement with Sheryl Dhillon to act as their Corporate Governance consultant. Ms. Dhillon is a highly experienced corporate secretary with over fifteen years of experience. She has extensive knowledge of corporate governance, as well as strong management skills and excellent corporate communications. Ms. Dhillon acts as Corporate Secretary for several TSXV and CSE listed companies.
“The addition of Mr. Bechtel and Ms. Dhillon is a significant value-add to the Primo team. Their cumulative experience in various disciplines will further empower the Company’s growth. It is an exciting time for our Company.” Comments from Mr. Andy Jagpal, CEO & President.
ON BEHALF OF THE BOARD OF DIRECTORS
President and Director
For further information, please contact Zoltan, IR Representative at:
Tweets by PRMONutra
FORWARD LOOKING STATEMENTS:
This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.